Medizinische Universität Graz - Research portal
Selected Publication:
Song, Q; Schmidt, AG; Hahn, HS; Carr, AN; Frank, B; Pater, L; Gerst, M; Young, K; Hoit, BD; McConnell, BK; Haghighi, K; Seidman, CE; Seidman, JG; Dorn, GW; Kranias, EG.
Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy.
J Clin Invest. 2003; 111(6): 859-867.
Doi: 10.1172/JCI16738
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Schmidt Albrecht
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Cardiac hypertrophy, either compensated or decompensated, is associated with cardiomyocyte contractile dysfunction from depressed sarcoplasmic reticulum (SR) Ca(2+) cycling. Normalization of Ca(2+) cycling by ablation or inhibition of the SR inhibitor phospholamban (PLN) has prevented cardiac failure in experimental dilated cardiomyopathy and is a promising therapeutic approach for human heart failure. However, the potential benefits of restoring SR function on primary cardiac hypertrophy, a common antecedent of human heart failure, are unknown. We therefore tested the efficacy of PLN ablation to correct hypertrophy and contractile dysfunction in two well-characterized and highly relevant genetic mouse models of hypertrophy and cardiac failure, Galphaq overexpression and human familial hypertrophic cardiomyopathy mutant myosin binding protein C (MyBP-C(MUT)) expression. In both models, PLN ablation normalized the characteristically prolonged cardiomyocyte Ca(2+) transients and enhanced unloaded fractional shortening with no change in SR Ca(2+) pump content. However, there was no parallel improvement in in vivo cardiac function or hypertrophy in either model. Likewise, the activation of JNK and calcineurin associated with Galphaq overexpression was not affected. Thus, PLN ablation normalized contractility in isolated myocytes, but failed to rescue the cardiomyopathic phenotype elicited by activation of the Galphaq pathway or MyBP-C mutations.
- Find related publications in this database (using NLM MeSH Indexing)
- Animals -
- Calcineurin - physiology
- Calcium - metabolism
- Calcium-Binding Proteins - physiology
- Cardiomegaly - genetics
- Carrier Proteins - physiology
- Connexin 43 - analysis
- GTP-Binding Protein alpha Subunits, Gq-G11 -
- Heart Failure - prevention and control
- Heterotrimeric GTP-Binding Proteins - physiology
- Mice -
- Mice, Knockout -
- Myocardial Contraction -
- Myocardium - metabolism
- Sarcoplasmic Reticulum - metabolism